Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Helen Torley. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Helen Torley har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:HALO / Halozyme Therapeutics, Inc. | PRESIDENT AND CEO, Director | 733 719 |
US:DGX / Quest Diagnostics Incorporated | Director | 6 260 |
US:RLYP / Relypsa, Inc. | Director | 0 |
US:ONXX / Onyx Pharmaceuticals Inc | EVP, Chief Commercial Officer | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Helen Torley. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp HALO / Halozyme Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i HALO / Halozyme Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2014-09-16 | HALO | Torley Helen | 50 000 | 8,9200 | 50 000 | 8,9200 | 446 000 | 309 | 24.7500 | 791 500 | 177,47 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i HALO / Halozyme Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Helen Torley som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 300 | 733 719 | −0,31 | 75,22 | −173 015 | 55 193 278 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 800 | 736 019 | −1,05 | 74,33 | −579 751 | 54 706 084 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 900 | 743 819 | −1,31 | 73,54 | −728 006 | 54 697 474 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 500 | 733 719 | −1,41 | 74,63 | −783 636 | 54 758 916 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 500 | 744 219 | −1,26 | 74,22 | −705 090 | 55 235 934 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 412 | 733 719 | −0,46 | 74,15 | −252 990 | 54 403 063 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −16 288 | 737 131 | −2,16 | 73,70 | −1 200 393 | 54 325 080 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −300 | 753 419 | −0,04 | 72,48 | −21 746 | 54 611 576 |
2025-09-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 052 | 733 719 | −0,68 | 64,83 | −327 511 | 47 565 535 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −14 948 | 738 771 | −1,98 | 64,14 | −958 839 | 47 388 466 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 958 | 733 719 | −0,94 | 64,00 | −445 319 | 46 958 750 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 042 | 740 677 | −1,73 | 63,24 | −824 802 | 46 841 895 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 283 | 733 719 | −0,17 | 63,60 | −81 596 | 46 663 061 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −18 717 | 735 002 | −2,48 | 63,01 | −1 179 321 | 46 311 006 |
2025-08-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 746 | 733 719 | −2,10 | 57,62 | −907 237 | 42 274 688 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 254 | 749 465 | −0,56 | 56,74 | −241 380 | 42 526 143 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −208 | 733 719 | −0,03 | 57,08 | −11 872 | 41 877 746 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −19 792 | 733 927 | −2,63 | 56,43 | −1 116 783 | 41 412 565 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −16 402 | 733 719 | −2,19 | 55,74 | −914 215 | 40 896 030 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 598 | 750 121 | −0,48 | 54,48 | −196 030 | 40 868 842 |
2025-07-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 511 | 733 719 | −2,07 | 53,91 | −836 214 | 39 555 525 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 489 | 749 230 | −0,60 | 53,11 | −238 406 | 39 790 856 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −20 000 | 733 719 | −2,65 | 52,57 | −1 051 460 | 38 573 809 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −20 000 | 733 719 | −2,65 | 52,96 | −1 059 200 | 38 857 758 |
2025-06-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 20 000 | 753 719 | 2,73 | 8,11 | 162 200 | 6 112 661 |
2025-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −12 081 | 733 719 | −1,62 | 57,75 | −697 678 | 42 372 272 | |
2025-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 22 436 | 745 800 | 3,10 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −9 087 | 723 364 | −1,24 | 58,29 | −529 681 | 42 164 888 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 875 | 732 451 | 2,36 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −11 313 | 715 576 | −1,56 | 58,29 | −659 435 | 41 710 925 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 009 | 726 889 | 2,98 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −38 668 | 705 880 | −5,19 | 58,29 | −2 253 958 | 41 145 745 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 71 810 | 744 548 | 10,67 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 098 | 672 738 | −1,04 | 58,29 | −413 742 | 39 213 898 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 679 836 | 1,96 | ||||
2024-12-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | −10 000 | 666 744 | −1,48 | ||||
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 404 | 676 744 | −0,35 | 53,91 | −129 590 | 36 480 562 |
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 615 | 679 148 | −0,24 | 53,31 | −86 096 | 36 205 380 |
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 981 | 680 763 | −0,87 | 51,85 | −310 097 | 35 295 519 |
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −900 | 676 744 | −0,13 | 54,57 | −49 116 | 36 931 950 |
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 100 | 677 644 | −1,33 | 53,94 | −490 845 | 36 551 440 |
2024-10-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 56,10 | −560 970 | 37 963 308 |
2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 56,34 | −563 370 | 38 125 727 |
2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 58,21 | −582 100 | 39 393 268 |
2024-09-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 59,20 | −592 030 | 40 065 275 |
2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 59,09 | −590 870 | 39 986 773 |
2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 59,09 | −590 890 | 39 988 126 |
2024-09-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 57,95 | −579 490 | 39 216 638 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −200 | 676 744 | −0,03 | 58,17 | −11 634 | 39 366 198 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 537 | 676 944 | −0,96 | 57,73 | −377 394 | 39 081 331 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 263 | 683 481 | −0,48 | 56,22 | −183 443 | 38 424 618 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 676 744 | −1,46 | 56,25 | −562 490 | 38 066 173 |
2024-08-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 686 744 | 1,48 | 13,87 | 138 700 | 9 525 139 |
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −9 070 | 676 744 | −1,32 | 36,10 | −327 427 | 24 430 458 | |
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 875 | 685 814 | 2,52 | ||||
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −11 292 | 668 939 | −1,66 | 36,10 | −407 641 | 24 148 698 | |
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 009 | 680 231 | 3,19 | ||||
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −17 619 | 659 222 | −2,60 | 35,91 | −632 698 | 23 672 662 | |
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
A - Award | 32 781 | 676 841 | 5,09 | ||||
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 036 | 644 060 | −1,08 | 35,91 | −252 663 | 23 128 195 | |
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 651 096 | 2,05 | ||||
2024-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −16 943 | 638 004 | −2,59 | 35,49 | −601 307 | 22 642 762 | |
2024-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 281 | 654 947 | 5,02 | ||||
2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 42,82 | −428 170 | 26 703 507 |
2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 42,85 | −428 540 | 26 726 583 |
2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 42,40 | −424 020 | 26 444 686 |
2023-08-31 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 43,18 | −431 820 | 26 931 145 |
2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 43,53 | −435 320 | 27 149 428 |
2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 43,77 | −437 680 | 27 296 613 |
2023-08-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 43,79 | −437 900 | 27 310 334 |
2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 42,69 | −426 890 | 26 623 678 |
2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 42,80 | −427 960 | 26 690 410 |
2023-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 13,87 | 138 700 | 8 788 947 |
2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 42,73 | −427 270 | 26 647 377 |
2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 14,66 | 146 600 | 9 289 544 |
2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 43,26 | −432 590 | 26 979 167 |
2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 14,66 | 146 600 | 9 289 544 |
2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 623 666 | −1,58 | 45,47 | −454 690 | 28 357 469 |
2023-03-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 633 666 | 1,60 | 14,66 | 146 600 | 9 289 544 |
2023-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | −10 000 | 623 666 | −1,58 | ||||
2023-02-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 061 | 633 666 | −1,72 | 49,26 | −544 865 | 31 214 387 | |
2023-02-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 010 | 644 727 | 3,37 | ||||
2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −6 892 | 623 717 | −1,09 | 49,20 | −339 086 | 30 686 876 | |
2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 630 609 | 2,12 | ||||
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −17 266 | 617 517 | −2,72 | 48,92 | −844 653 | 30 208 932 | |
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 794 | 634 783 | 5,45 | ||||
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −16 469 | 601 989 | −2,66 | 48,92 | −805 663 | 29 449 302 | |
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 281 | 618 458 | 5,33 | ||||
2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 50,40 | −504 000 | 29 593 721 |
2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 51,36 | −513 570 | 30 155 649 |
2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 51,26 | −512 580 | 30 097 519 |
2023-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 52,41 | −524 140 | 30 776 295 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 51,05 | −510 470 | 29 973 624 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 103 | 587 177 | −0,19 | 50,93 | −56 175 | 29 904 337 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 897 | 588 280 | −1,49 | 50,40 | −448 364 | 29 646 371 |
2023-01-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −896 | 587 177 | −0,15 | 58,20 | −52 145 | 34 171 940 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 104 | 588 073 | −1,52 | 57,29 | −521 550 | 33 689 526 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 58,30 | −582 980 | 34 231 245 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −493 | 587 177 | −0,08 | 59,12 | −29 146 | 34 713 904 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 507 | 587 670 | −1,59 | 58,64 | −557 481 | 34 460 381 |
2022-12-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 52,15 | −521 490 | 30 620 693 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 587 177 | −1,67 | 53,90 | −538 990 | 31 648 253 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 | 587 177 | 0,00 | 54,60 | −710 | 32 062 800 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 987 | 587 190 | −1,67 | 54,11 | −540 437 | 31 775 200 |
2022-11-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 597 177 | 1,70 | 14,66 | 146 600 | 8 754 615 |
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 84 037 | 84 037 | |||||
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 257 046 | 257 046 | |||||
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −13 092 | 39 276 | −25,00 | ||||
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −6 892 | 587 177 | −1,16 | 34,43 | −237 292 | 20 216 504 | |
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 13 092 | 594 069 | 2,25 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −28 729 | 0 | −100,00 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −15 125 | 580 977 | −2,54 | 33,64 | −508 805 | 19 544 066 | |
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 729 | 596 102 | 5,06 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −32 795 | 32 794 | −50,00 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −17 266 | 567 373 | −2,95 | 34,20 | −590 497 | 19 404 157 | |
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 795 | 584 639 | 5,94 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −31 282 | 62 562 | −33,33 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −16 598 | 551 844 | −2,92 | 34,94 | −579 934 | 19 281 429 | |
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 282 | 568 442 | 5,82 | ||||
2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −50 000 | 150 000 | −25,00 | 14,66 | −733 000 | 2 199 000 |
2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 225 | 537 160 | −2,23 | 40,42 | −494 122 | 21 711 470 |
2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −37 775 | 549 385 | −6,43 | 39,62 | −1 496 646 | 21 766 634 |
2021-11-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −50 000 | 200 000 | −20,00 | 14,66 | −733 000 | 2 932 000 |
2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 857 | 537 160 | −1,08 | 40,95 | −239 862 | 21 998 313 |
2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −44 143 | 543 017 | −7,52 | 39,97 | −1 764 528 | 21 706 019 |
2021-10-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −50 000 | 250 000 | −16,67 | 14,66 | −733 000 | 3 665 000 |
2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 560 | 537 160 | −1,21 | 42,98 | −281 942 | 23 086 600 |
2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −43 440 | 543 720 | −7,40 | 42,29 | −1 836 904 | 22 991 744 |
2021-09-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −50 000 | 300 000 | −14,29 | 14,66 | −733 000 | 4 398 000 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 048 | 537 160 | −0,19 | 46,11 | −48 323 | 24 768 448 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 538 208 | −0,09 | 44,91 | −22 454 | 24 169 845 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 538 708 | −0,07 | 43,26 | −17 304 | 23 304 508 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 000 | 539 108 | −0,19 | 42,64 | −42 640 | 22 987 565 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −21 914 | 540 108 | −3,90 | 41,47 | −908 752 | 22 397 739 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −25 138 | 562 022 | −4,28 | 40,42 | −1 016 103 | 22 717 491 |
2021-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 350 000 | −12,50 | 14,66 | −733 000 | 5 131 000 | |
2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −50 000 | 537 160 | −8,52 | 45,97 | −2 298 650 | 24 694 857 |
2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-06-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 400 000 | −11,11 | 14,66 | −733 000 | 5 864 000 | |
2021-06-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −50 000 | 537 160 | −8,52 | 39,66 | −1 982 950 | 21 303 228 |
2021-06-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-05-25 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 363 | 6 260 | 27,83 | ||||
2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 450 000 | −10,00 | 14,66 | −733 000 | 6 597 000 | |
2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 066 | 537 160 | −0,20 | 44,84 | −47 803 | 24 087 866 |
2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 956 | 538 226 | −0,73 | 44,10 | −174 479 | 23 738 458 |
2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −36 522 | 542 182 | −6,31 | 43,05 | −1 572 236 | 23 340 393 |
2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 456 | 578 704 | −1,44 | 42,17 | −356 581 | 24 403 369 |
2021-05-11 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-04-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 500 000 | −9,09 | 14,66 | −733 000 | 7 330 000 | |
2021-04-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −50 000 | 537 160 | −8,52 | 42,54 | −2 127 250 | 22 853 472 |
2021-04-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 550 000 | −8,33 | 14,66 | −733 000 | 8 063 000 | |
2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −33 890 | 537 160 | −5,93 | 46,48 | −1 575 112 | 24 965 693 |
2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −16 110 | 571 050 | −2,74 | 45,58 | −734 342 | 26 030 172 |
2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 587 160 | 9,31 | 14,66 | 733 000 | 8 607 766 |
2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −39 354 | 0 | −100,00 | ||||
2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −19 511 | 537 160 | −3,50 | 48,69 | −949 991 | 26 154 320 | |
2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 39 354 | 556 671 | 7,61 | ||||
2021-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 52 368 | 52 368 | |||||
2021-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 90 134 | 90 134 | |||||
2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −28 729 | 28 729 | −50,00 | ||||
2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −14 243 | 517 317 | −2,68 | 49,84 | −709 871 | 25 783 079 | |
2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 729 | 531 560 | 5,71 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −32 795 | 65 589 | −33,33 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −16 259 | 502 831 | −3,13 | 49,84 | −810 349 | 25 061 097 | |
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 795 | 519 090 | 6,74 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −31 282 | 93 844 | −25,00 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −15 509 | 486 295 | −3,09 | 50,60 | −784 755 | 24 606 527 | |
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 31 282 | 501 804 | 6,65 | ||||
2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 600 000 | −7,69 | 14,66 | −733 000 | 8 796 000 | |
2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 437 | 470 522 | −1,14 | 48,51 | −263 736 | 22 823 893 |
2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −44 563 | 475 959 | −8,56 | 47,76 | −2 128 182 | 22 730 231 |
2021-02-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 520 522 | 10,63 | 14,66 | 733 000 | 7 630 853 |
2020-11-30 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | −10 000 | 470 522 | −2,08 | ||||
2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −50 000 | 650 000 | −7,14 | 14,66 | −733 000 | 9 529 000 | |
2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | −27 674 | 480 522 | −5,45 | 41,18 | −1 139 643 | 19 788 376 | |
2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | −22 326 | 508 196 | −4,21 | 40,17 | −896 925 | 20 416 266 | |
2020-11-25 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 50 000 | 530 522 | 10,41 | 14,66 | 733 000 | 7 777 453 | |
2020-08-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | −10 000 | 480 522 | −2,04 | ||||
2020-05-21 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 531 | 4 897 | 45,48 | ||||
2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −39 354 | 39 354 | −50,00 | ||||
2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −19 511 | 490 522 | −3,83 | 21,83 | −425 925 | 10 708 095 | |
2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 39 354 | 510 033 | 8,36 | ||||
2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −28 730 | 57 458 | −33,33 | ||||
2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −14 244 | 470 679 | −2,94 | 21,10 | −300 548 | 9 931 327 | |
2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 730 | 484 923 | 6,30 | ||||
2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −32 795 | 98 384 | −25,00 | ||||
2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −16 259 | 456 193 | −3,44 | 20,00 | −325 180 | 9 123 860 | |
2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 32 795 | 472 452 | 7,46 | ||||
2020-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 125 126 | 125 126 | |||||
2020-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 266 051 | 266 051 | |||||
2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −55 487 | 0 | −100,00 | ||||
2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −19 910 | 439 657 | −4,33 | 19,21 | −382 471 | 8 445 811 | |
2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 55 487 | 459 567 | 13,73 | ||||
2020-02-04 |
|
5 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
G - Gift | −12 500 | 404 080 | −3,00 | ||||
2019-05-16 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 722 | 3 366 | 104,74 | ||||
2019-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −39 354 | 78 708 | −33,33 | ||||
2019-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −19 511 | 416 580 | −4,47 | 16,81 | −327 980 | 7 002 710 | |
2019-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 39 354 | 436 091 | 9,92 | ||||
2019-02-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −28 730 | 86 188 | −25,00 | ||||
2019-02-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −14 244 | 396 737 | −3,47 | 16,54 | −235 596 | 6 562 030 | |
2019-02-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 28 730 | 410 981 | 7,52 | ||||
2019-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 131 179 | 131 179 | |||||
2019-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 250 218 | 250 218 | |||||
2019-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −31 250 | 0 | −100,00 | ||||
2019-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −14 547 | 382 251 | −3,67 | 16,73 | −243 371 | 6 395 059 | |
2019-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 396 798 | 8,55 | ||||
2019-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −55 487 | 55 487 | −50,00 | ||||
2019-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −19 425 | 365 548 | −5,05 | 16,12 | −313 131 | 5 892 634 | |
2019-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 55 487 | 384 973 | 16,84 | ||||
2018-10-03 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 298 | 1 298 | |||||
2018-07-05 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 297 | 1 297 | |||||
2018-06-05 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 665 | 665 | |||||
2018-05-17 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 644 | 1 644 | |||||
2018-02-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −39 354 | 118 062 | −25,00 | ||||
2018-02-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −19 511 | 329 486 | −5,59 | 19,28 | −376 172 | 6 352 490 | |
2018-02-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 39 354 | 348 997 | 12,71 | ||||
2018-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 114 918 | 114 918 | |||||
2018-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 201 552 | 201 552 | |||||
2018-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −31 250 | 31 250 | −50,00 | ||||
2018-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −15 493 | 309 643 | −4,77 | 18,25 | −282 747 | 5 650 985 | |
2018-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 325 136 | 10,63 | ||||
2018-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −55 487 | 110 974 | −33,33 | ||||
2018-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −24 111 | 293 886 | −7,58 | 18,37 | −442 919 | 5 398 686 | |
2018-02-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 55 487 | 317 997 | 21,14 | ||||
2018-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2018-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −11 649 | 262 510 | −4,25 | 19,46 | −226 690 | 5 108 445 | |
2018-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 274 159 | 12,29 | ||||
2017-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 157 416 | 157 416 | |||||
2017-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 251 923 | 251 923 | |||||
2017-02-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −31 250 | 62 500 | −33,33 | ||||
2017-02-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 244 159 | 14,68 | ||||
2017-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −55 487 | 166 461 | −25,00 | ||||
2017-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 55 487 | 212 909 | 35,25 | ||||
2017-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −30 000 | 30 000 | −50,00 | ||||
2017-01-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 157 422 | 23,54 | ||||
2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | −4 500 | 0 | −100,00 | ||||
2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | −4 500 | 0 | −100,00 | ||||
2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | −12 000 | 0 | −100,00 | ||||
2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
D - Sale to Issuer | −2 250 | 0 | −100,00 | 32,00 | −72 000 | ||
2016-09-02 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
U - Other | −1 237 | 2 250 | −35,47 | 32,00 | −39 584 | 72 000 | |
2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Performance Stock Units |
M - Exercise | −13 500 | 0 | −100,00 | ||||
2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Performance Stock Units |
A - Award | 13 500 | 13 500 | |||||
2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −7 044 | 127 422 | −5,24 | 8,63 | −60 790 | 1 099 652 | |
2016-07-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 13 500 | 134 466 | 11,16 | ||||
2016-06-23 |
|
4 | RLYP |
Relypsa Inc
Stock Option (Right to Buy) |
A - Award | 4 500 | 4 500 | |||||
2016-06-23 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
A - Award | 2 250 | 3 487 | 181,89 | ||||
2016-06-08 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
S - Sale | −1 013 | 1 237 | −45,02 | 19,32 | −19 570 | 23 897 | |
2016-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −31 250 | 93 750 | −25,00 | ||||
2016-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −11 743 | 120 966 | −8,85 | 7,90 | −92 770 | 955 631 | |
2016-02-09 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 31 250 | 132 709 | 30,80 | ||||
2016-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 221 948 | 221 948 | |||||
2016-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 376 569 | 376 569 | |||||
2016-01-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −30 000 | 60 000 | −33,33 | ||||
2016-01-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −11 686 | 101 459 | −10,33 | 15,77 | −184 288 | 1 600 008 | |
2016-01-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 113 145 | 36,08 | ||||
2016-01-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −16 436 | 83 145 | −16,51 | 17,33 | −284 836 | 1 440 903 | |
2016-01-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 31 500 | 99 581 | 46,27 | ||||
2015-06-08 |
|
4 | RLYP |
Relypsa Inc
Stock Option (right to buy) |
A - Award | 4 500 | 4 500 | |||||
2015-06-08 |
|
4 | RLYP |
Relypsa Inc
Common Stock |
A - Award | 2 250 | 2 250 | |||||
2015-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 125 000 | 125 000 | |||||
2015-02-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 200 000 | 200 000 | |||||
2015-01-26 |
|
4 | RLYP |
Relypsa Inc
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2015-01-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −30 000 | 90 000 | −25,00 | ||||
2015-01-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
F - Taxes | −11 919 | 68 081 | −14,90 | 10,06 | −119 905 | 684 895 | |
2015-01-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 80 000 | 60,00 | ||||
2014-09-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 50 000 | 50 000 | 8,92 | 446 000 | 446 000 | ||
2014-01-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Restricted Stock Units |
A - Award | 120 000 | 120 000 | |||||
2014-01-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
A - Award | 700 000 | 700 000 | 14,66 | 10 262 000 | 10 262 000 | ||
2014-01-08 | 3 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
0 | ||||||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −24 300 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −12 156 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −1 144 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −44 132 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −11 868 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −28 575 | 0 | −100,00 | 125,00 | −3 571 875 | ||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
U - Other | −7 336 | 28 575 | −20,43 | 125,00 | −917 000 | 3 571 875 | |
2013-09-05 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 099 | 35 911 | −5,52 | 123,62 | −259 478 | 4 439 318 |
2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 250 | 13 300 | −8,59 | ||||
2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 000 | 56 000 | −11,11 | ||||
2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 061 | 46 585 | −2,23 | 126,92 | −134 667 | 5 912 801 |
2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 250 | 47 646 | −14,76 | 126,89 | −1 046 810 | 6 045 615 |
2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 55 896 | 2,29 | 37,68 | 47 100 | 2 106 161 | |
2013-08-14 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 54 646 | 14,69 | 33,70 | 235 900 | 1 841 570 | |
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 250 | 14 450 | −7,96 | ||||
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 000 | 63 000 | −10,00 | ||||
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 47 646 | −2,06 | 97,26 | −97 260 | 4 634 055 |
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 48 646 | −4,89 | 98,28 | −245 690 | 4 780 739 |
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 51 146 | −5,54 | 98,78 | −296 352 | 5 052 406 |
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 750 | 54 146 | −3,13 | 97,32 | −170 308 | 5 269 413 |
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 55 896 | 14,32 | 33,70 | 235 900 | 1 883 695 | |
2013-05-15 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 48 896 | 2,62 | 37,68 | 47 100 | 1 842 401 | |
2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −466 | 47 646 | −0,97 | 86,14 | −40 141 | 4 104 226 |
2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 24 300 | 24 300 | |||||
2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 8 600 | 48 112 | 21,77 | ||||
2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 250 | 15 800 | −7,33 | ||||
2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 000 | 70 000 | −9,09 | ||||
2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 250 | 39 512 | −17,27 | 78,61 | −648 532 | 3 106 038 |
2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 47 762 | 2,69 | 37,68 | 47 100 | 1 799 672 | |
2013-02-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 46 512 | 17,72 | 33,70 | 235 900 | 1 567 454 | |
2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 250 | 17 050 | −6,83 | ||||
2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 000 | 77 000 | −8,33 | ||||
2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 997 | 39 512 | −23,29 | 75,22 | −902 414 | 2 972 093 |
2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 250 | 51 509 | 2,49 | 37,68 | 47 100 | 1 940 859 | |
2012-11-30 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 50 259 | 16,18 | 33,70 | 235 900 | 1 693 728 | |
2012-10-05 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 314 | 43 259 | −5,08 | 86,51 | −200 184 | 3 742 336 |
2012-09-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 878 | 56 823 | −3,20 | 72,78 | −136 681 | 4 135 578 |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 58 701 | −3,29 | 71,89 | −143 780 | 4 220 015 | |
2012-07-27 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 549 | 60 701 | −6,97 | 73,97 | −336 498 | 4 490 168 |
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 18 300 | 18 300 | |||||
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 17 150 | 65 250 | 35,65 | ||||
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 3 600 | 48 100 | 8,09 |